ACCCBUZZ BLOG

The newest Oncology Issues is here, opening the year with a spotlight on the six 2025 ACCC Innovators: Fox Chase Cancer Center, Lifepoint Health, Penn Medicine Princeton Health, WellSpan Cancer Institute, Highlands Oncology, and Shaw Cancer Center.

This National Cancer Prevention Month, it is vital that the oncology community identify effective and sustainable strategies to encourage prevention measures and reduce the burden of cancer on both individuals and a strained health care infrastructure.

Keynote speaker at the upcoming 2026 ACCC Leadership Summit Michelle Rozen, PhD shares her insights about navigating AI-driven change as a health care leader.

For 52 years, the ACCC has pursued its mission to provide resources, forums, and opportunities to promote the delivery of high-quality, equitable cancer care. Learn more about the work of ACCC over the past year in the full 2025 Impact Report.

This January, ACCC invites its membership to take part in promoting cervical cancer awareness by sharing resources and research about the importance of the HPV vaccine and regular screening, to work towards a future free of cervical cancer.

To broaden access to the specialized support and navigation that patients with primary brain tumors need, the Brain Tumor Network partnered with the American Cancer Society.

The NCCN hosted a patient advocacy summit as a forum for providers, advocates, and industry members to discuss the varied and unique cancer care needs of Veterans and first responders.

Introducing Oncology Unscripted, ACCC’s new CANCER BUZZ podcast, which offers unfiltered, honest dialogue about the future of cancer care delivery and fresh perspectives on how oncology professionals can think bigger, lead smarter, and act bolder.

In honor of the great sacrifice of Veterans and first responders and in pursuit of improving awareness, health literacy, and availability of assistance programs, the NCCN hosted a patient advocacy summit on December 9, 2025, in the nation’s capital.

This installment of Oncology Issues emphasizes collaboration, whether between oncology and other medical specialties, between surgeons, or between the cancer care community and policy makers.

In honor of National Oncology Navigator Day, ACCC is pleased to share several initiatives from cancer programs across the country who are leveraging navigators in creative and successful ways.

November is National Family Caregivers Month, and ACCC is taking this important opportunity to honor the millions of individuals who play an essential role in the lives of loved ones navigating serious illness.

In recognition of Lung Cancer Awareness Month, ACCC spotlights the ongoing need for more robust research, expanded treatment options, and early diagnosis and intervention for a disease that, though it impacts millions of lives, is often under-discussed.

In recognition of Bladder Health Awareness Month, ACCC shares the results of a recent quality improvement study, which provides impactful steps cancer centers can take to mitigate disparities in bladder cancer.

For many community sites, the question is not whether to offer BsAbs but how to implement them safely and sustainably. Recognizing these needs, ACCC developed 2 practical, implementation-focused tools to support programs at every stage of readiness.

ACCC is excited to share its new provider resources for TIL cell therapy, including a referral readiness checklist, patient pathway guide, and white paper with tangible steps for improving access.

The JADPRO Live 2025 conference convened thousands of APPs in hematology and oncology for 4 days of clinical education, collaboration, and professional growth.

Breast Cancer Awareness Month, observed each year in October, recognizes the research, advocacy, and strength of patients that have led to treatment advances for the most common cancer diagnosis in women.

In recognition of the importance of mental well-being and mental health services, ACCC highlights 3 thought leadership pieces featured in recent volumes of Oncology Issues that tackle mental health–forward interventions for both patients and providers.

A panel of industry leaders gathered to unpack the potential impacts of the administration’s actions relating to Most Favored Nation (MFN) drug pricing, offering insight into what MFN could mean for pharmaceutical companies, payers, and patients.

The recent NCCN summit provided an opportunity for providers, payers, and patient advocates to discuss policy and strategies on the current application of AI in practice, its promise for care improvement, and strategies to mitigate the risks AI poses.

The NCCN hosted a 1-day summit on September 9 all about AI in cancer care: how it’s being used today, where the field is moving in the future, and challenges that will require innovative and collaborative solutions.

In honor of Hereditary Cancer Awareness Week, observed this year from September 29 to October 5, ACCC is highlighting 2 initiatives from its member programs that expanded genetic testing for hereditary cancers.

A recent ACCC virtual office hours session unpacked the real-world challenges of Bispecific Antibodies—from reimbursement roadblocks to operational logistics—and offered strategies to navigate them more effectively.

September is Gynecologic Cancer Awareness Month, a chance to highlight cancers that originate in the endometrium, ovary, and cervix, and to recognize efforts to improve patient outcomes for cancer types with poor prognoses and limited treatment options.

Supporting AYAs with cancer truly takes a village. Multidisciplinary collaboration, community partnerships, survivorship champions, and patient voices are all essential to building programs that meet the needs of this diverse population.